Physician

Amy Michelle Wasserman, M.D.

According to 2025 Medicare claims, Amy Wasserman, M.D. (NPI: 1003056268) practices rheumatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Westchester, NY. This provider's primary affiliated billing organization is WESTCHESTER MEDICAL CENTER ADVANCED PHYSICIAN SERVICES, PC (NPI: 1912131392; TIN: 26-4709927) and primary practice location at 10532-2140.

Wasserman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 106 traditional Medicare patients, billed 280 HCPCS/CPT codes, and received $24,536 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 755 prescription claims across 113 beneficiaries totaling $1,030,961 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 2 records totaling $119. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $23,785 and ending at $24,536. Concurrently, Part D prescription costs have risen steadily, from $75,685 to $1,030,961. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	103	288	$23,785
2016	147	433	$35,833
2017	124	321	$26,046
2018	142	323	$28,555
2019	133	295	$25,488
2020	98	189	$15,161
2021	111	184	$19,760
2022	138	226	$24,129
2023	99	153	$16,871
2024	106	280	$24,536

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	58	259	$75,685
2016	83	454	$250,028
2017	78	437	$390,021
2018	83	456	$474,929
2019	82	610	$809,010
2020	85	724	$1,120,398
2021	72	594	$1,008,533
2022	81	606	$713,953
2023	89	737	$959,113
2024	113	755	$1,030,961

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	35	64	$152
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	19	19	$128
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	11	11	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	40	58	$96
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	45	85	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	38	1,064	$333,692
Rinvoq	Upadacitinib	15	510	$109,887
Simponi	Golimumab	14	480	$98,638
Orencia Clickject	Abatacept	16	450	$92,426
Humira Pen	Adalimumab	13	364	$88,886

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$119	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy Michelle Wasserman, M.D.?

Tedicare shows public-source Medicare data for Amy Michelle Wasserman, M.D. (NPI 1003056268), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Michelle Wasserman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amy Michelle Wasserman, M.D.?

Amy Michelle Wasserman, M.D. is linked to WESTCHESTER MEDICAL CENTER ADVANCED PHYSICIAN SERVICES, PC (billing NPI 1912131392) in the available physician profile data.

Does Amy Michelle Wasserman, M.D. have Open Payments data?

Amy Michelle Wasserman, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.